| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 3Alpha-当归酰氧基-9beta-羟基等效贝壳杉; 3alpha-Angeloyloxypterokaurene L3 | CFN97677 | 79406-11-4 | C25H36O5 = 416.56 | 5mg | QQ客服：2159513211 |
| 对映-3beta-肉桂酰氧基贝壳杉-16-烯-19; ent-3beta-Cinnamoyloxykaur-16-en-19-oic acid | CFN97678 | 79406-10-3 | C29H36O4 = 448.60 | 5mg | QQ客服：2056216494 |
| 9Beta-羟基-对映贝壳杉-16-烯酸; Pterokaurene L3 | CFN97685 | 77658-38-9 | C20H30O3 = 318.46 | 5mg | QQ客服：3257982914 |
| 岩大戟内酯B; Jolkinolide B | CFN90245 | 37905-08-1 | C20H26O4 = 330.42 | 20mg | QQ客服：1413575084 |
| 叶含荚宁C; Vibsanin C | CFN97692 | 74690-89-4 | C25H36O5 = 416.56 | 5mg | QQ客服：2056216494 |
| 香紫苏醇; Sclareol | CFN90249 | 515-03-7 | C20H36O2 = 308.50 | 20mg | QQ客服：2159513211 |
| 6alpha-羟基尼刀瑞尔醇; 6alpha-Hydroxynidorellol | CFN97701 | 70387-38-1 | C20H34O3 = 322.49 | 5mg | QQ客服：1413575084 |
| 异贝壳杉烯酸, 贝壳杉烯酸; Kaurenoic acid | CFN97703 | 6730-83-2 | C20H30O2 = 302.46 | 20mg | QQ客服：2056216494 |
| 莱苞迪甙D； 莱苞迪苷D; Rebaudioside D | CFN90257 | 63279-13-0 | C50H80O28 = 1129.15 | 20mg | QQ客服：3257982914 |
| 莱苞迪甙C； 莱苞迪苷C; Rebaudioside C | CFN90258 | 63550-99-2 | C44H70O22 = 951.02 | 20mg | QQ客服：2159513211 |
| 异海松酸; Isopimaric acid | CFN97723 | 5835-26-7 | C20H30O2 = 302.46 | 5mg | QQ客服：2056216494 |
| 桃柁酚; Totarol | CFN97733 | 511-15-9 | C20H30O = 286.46 | 20mg | QQ客服：2159513211 |
| 植酮; Phytone | CFN97734 | 502-69-2 | C18H36O = 268.48 | 20mg | QQ客服：1457312923 |
| ent-17-羟基贝壳杉-15-烯-19-酸; ent-17-Hydroxykaur-15-en-19-oic acid | CFN97752 | 35030-38-7 | C20H30O3 = 318.46 | 5mg | QQ客服：2056216494 |
| Dodonolide; Dodonolide | CFN97753 | 349534-73-2 | C20H24O3 = 312.41 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)